Review Finds Intra‑Arterial Stem Cell Therapy Promising for Stroke Recovery

Researchers from the University of Miami Miller School of Medicine, together with collaborators from multiple institutions, have released a comprehensive review of intra‑arterial stem cell therapy as a treatment for ischemic stroke. The paper, published in a peer‑reviewed journal, surveys recent preclinical and clinical studies that explore delivering stem cells directly into the cerebral arteries to target damaged brain tissue. The authors note that, while advances such as thrombolysis and mechanical thrombectomy have reduced mortality, many patients continue to experience long‑term disability, prompting investigation into regenerative approaches.

The review outlines the biological rationale for intra‑arterial delivery, including the potential for stem cells to modulate inflammation, promote angiogenesis, and replace lost neuronal cells. It summarizes findings from early‑phase trials that report modest improvements in motor and cognitive outcomes, as well as safety data indicating a low incidence of adverse events such as hemorrhage or embolic complications. The authors also discuss methodological challenges, including optimal cell type, dosing, timing relative to stroke onset, and imaging techniques for tracking cell migration.

Concluding, the authors suggest that intra‑arterial stem cell therapy holds promise as an adjunctive strategy to enhance functional recovery in stroke survivors, but emphasize that larger, randomized controlled trials are needed to establish efficacy, standardize protocols, and determine long‑term benefits. The review aims to guide future research and inform clinicians about the evolving landscape of regenerative stroke treatment.